BioAsia Licensing and Deal-Making Summit-SRI Conference. Life science partnering and investment on the Pacific Rim 2-3 August, 2004, Coronado, CA, USA..
The Strategic Research Institute's inaugural BioAsia Licensing and Deal-Making Summit, co-organized by the BioMinerva Group, attracted industrial leaders in biotechnology and pharmaceuticals from both sides of the Pacific Ocean. Topics discussed at the 2-day conference spanned from trans-Pacific licensing and partnering trends led by Japan-US deals, the changing landscape of the Japanese pharmaceutical industry, and trans-Pacific partnering strategies to perspectives of Asia-Pacific markets and successful investment strategies. The emerging Chinese biotechnology and pharmaceutical industry was also covered prominently, including assessments of the Chinese market, discussions on intellectual property, regulatory and tax issues, as well as case studies of Sino-US collaborations and technology showcases from Chinese biotech companies.
Xu
Jing
J
BioMinerva Group, 11553 Hadar Drive, San Diego, CA 92126, USA. jxu4@san.rr.com
D001709:Biotechnology / Q000639:trends*; D002140:California; D002681:China; D015195:Drug Design; D004345:Drug Industry / Q000639:trends*; D006801:Humans; D018973:Intellectual Property; D007391:International Cooperation; D007449:Investments; D007564:Japan; D008004:Licensure; D018581:Technology Transfer; D013678:Technology, Pharmaceutical; D014481:United States